STAPHYLOCOCCUS AUREUS SENSITIVITY TO ANTIBIOTICS IN CHILDREN WITH ATOPIC DERMATITIS



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The aim of this study was to assess the antibiotic resistance of S. aureus isolated from the skin of atopic dermatitis (AD) children. Materials and methods. 256 AD children were included in the study in 2014-2016. Microbiological examination of skin scraping and determination of antibiotics sensitivity were performed. Results. Staphylococcus aureus was isolated in 173 (67,6%) of 256 patients. Resistance to erythromycin was established in 64,6 and 74,6%, respectively. Retrospective analyses showed that S. aureus became more sensitive to ampicillin, ceftriaxone, ciprofloxacin but more resistant to erythromycin. Conclusion. Ceftriaxone and cefoxitin but not erythromycin and ampicillin are the drugs of choice for the treatment of atopic dermatitis complicated by secondary infection in children.

Full Text

Restricted Access

About the authors

E E Varlamov

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

Email: evarlamov@pedklin.ru
2, Таldomskaya str., Moscow, 125412, Russia

E S Fedenko

NRC Institute of Immunology FMBA of Russia

24, Kashirskoe Shosse, Moscow, 115478, Russia

M C Treneva

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

2, Таldomskaya str., Moscow, 125412, Russia

V R Voronina

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

2, Таldomskaya str., Moscow, 125412, Russia

Z V Zaporozhtseva

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

2, Таldomskaya str., Moscow, 125412, Russia

M A Ilyasova

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

2, Таldomskaya str., Moscow, 125412, Russia

A N Pampura

Research Clinical Institute of Pediatrics named after academician Y.E. Veltishev

2, Таldomskaya str., Moscow, 125412, Russia

O G Elisyutina

NRC Institute of Immunology FMBA of Russia

24, Kashirskoe Shosse, Moscow, 115478, Russia

References

  1. Van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol. 2007; 120(3): 565-569.
  2. Park JM, Jo JH, Jin H, Ko HC, Kim MB, Kim JM et al. Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period. Ann Dermatol. 2016; 28: 470-478.
  3. Hon KL, Tsang KY, Kung JS, Leung TF, Lam CW, Wong CK. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers. Molecules. 2017; 22: pii: E291. doi: 10.3390/molecules22020291.
  4. Bell MC, Stovall SH, Scurlock AM, Perry TT, Jones SM, Harik NS. Addressing antimicrobial resistance to treat children with atopic dermatitis in a tertiary pediatric allergy clinic. Clin Pediatr (Phila). 2012; 51: 1025-1029.
  5. Bessa GR, Quinto VP, Machado DC, Perry TT, Jones SM, Harik NS. Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis. An Bras Dermatol. 2016; 91: 604-610.
  6. Ong PY, Leung DY The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010; 30: 309-321.
  7. Leung DY. Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol. 2001; 45: 13-16.
  8. Leung DY, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM et al. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. Br J Dermatol. 2009; 161(2): 435-443.
  9. Тренева МС, Пампура АН, Феденко ЕС, Воронина ВР, Илясова МА. Динамика антибиотикорезистентности золотистого стафилококка кожи у детей с атопическим дерматитом. Ros Vestn Perinatol Pediat, 2011; (6): 98-101

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2017



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies